Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes

NCT01928888 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

559

Enrollment

INDUSTRY

Sponsor class

Conditions

Heartburn

Interventions

DRUG: Talcid (Hydrotalcite, BAY4516H)
DRUG: Famotidine
DRUG: Placebo

Sponsor

Bayer